Cargando…

Very long‐term prognosis in patients with hypertrophic cardiomyopathy: a longitudinal study with a period of 20 years

AIMS: We aim to clarify the prognosis on patients with hypertrophic cardiomyopathy (HCM) for a follow‐up period of more than 10 years. METHODS AND RESULTS: We retrospectively analysed 102 consecutive patients with HCM diagnosed by 31 December 2000. Complete and detailed clinical records were obtaine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugiura, Kenta, Kubo, Toru, Ochi, Yuri, Miyagawa, Kazuya, Baba, Yuichi, Noguchi, Tatsuya, Hirota, Takayoshi, Yamasaki, Naohito, Doi, Yoshinori L., Kitaoka, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288772/ https://www.ncbi.nlm.nih.gov/pubmed/35652322 http://dx.doi.org/10.1002/ehf2.13983

Ejemplares similares

Elevation of high‐sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2020)

A Case Report of Asymmetry of Systolic Anterior Motion of the Mitral Valve, a Not Widely Well-Known but Practically Important Echocardiographic Presentation in Hypertrophic Cardiomyopathy
por: Ochi, Yuri, et al.
Publicado: (2021)

Clinical significance of new‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2021)

Wild-Type Transthyretin Amyloidosis in Female Patients　― Consideration of Sex Differences ―
por: Ochi, Yuri, et al.
Publicado: (2021)

Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I
por: Sugiura, Kenta, et al.
Publicado: (2020)

Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study
por: Kubo, Toru, et al.
Publicado: (2015)

Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis
por: Ochi, Yuri, et al.
Publicado: (2020)

Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort　― Results From the Kochi RYOMA Study ―
por: Kubo, Toru, et al.
Publicado: (2020)

Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release
por: Sugiura, Kenta, et al.
Publicado: (2021)

Transient decrease in the depth of the negative T wave in apical hypertrophic cardiomyopathy is a sign of left anterior descending artery stenosis: a case series
por: Arima, Naoki, et al.
Publicado: (2023)

A Drifting Dislodged Leadless Pacemaker in the Bilateral Pulmonary Arteries
por: Sugiura, Kenta, et al.
Publicado: (2022)

Importance of Paroxysmal Atrial Fibrillation and Sex Differences in the Prevention of Embolic Stroke in Hypertrophic Cardiomyopathy
por: Komatsu, Junya, et al.
Publicado: (2021)

A single atrial septal defect masquerading as multiple defects due to a refraction artifact – A cautionary note
por: Ochi, Yuri, et al.
Publicado: (2020)

Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis
por: Okamoto, Nao, et al.
Publicado: (2019)

High-sensitivity Cardiac Troponin T Is a Useful Biomarker for Predicting the Prognosis of Patients with Systemic Sarcoidosis Regardless of Cardiac Involvement
por: Baba, Yuichi, et al.
Publicado: (2023)

Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis　― Reply ―
por: Ochi, Yuri, et al.
Publicado: (2021)

Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy
por: Matsumura, Yoshihisa, et al.
Publicado: (2015)

Where Is the Left Atrial Appendage Wall? Caution during Transesophageal Echocardiography
por: Baba, Yuichi, et al.
Publicado: (2023)

Giant Left Atrial Myxoma in a Nonagenarian
por: Matsumura, Yoshihisa, et al.
Publicado: (2013)

Ruptured Thoracic Aortic Aneurysm Imaging Pulmonary Embolism
por: Baba, Yuichi, et al.
Publicado: (2018)

A Novel Disease Entity in Search of Its Own Identity　― Takotsubo Syndrome. Is It Really “Cardiomyopathy”? ―
por: Doi, Yoshinori L., et al.
Publicado: (2020)

Metastatic cardiac tumor from urothelial carcinoma detected by transthoracic echocardiography: a case report
por: Nakashima, Yasuteru, et al.
Publicado: (2015)

Takotsubo Syndrome in Octogenarians and Nonagenarians
por: Nishimura, Yu-ki, et al.
Publicado: (2021)

Premature Onset Aortic Stenosis in Systemic Sclerosis: A Report of a Series of Cases
por: Machida, Ayaka, et al.
Publicado: (2020)

Primary Cardiac Lymphoma: A Lesson Learned from an Unsuccessful Experience
por: Ito, Izumi, et al.
Publicado: (2018)

Physical examination in a case of hypertrophic obstructive cardiomyopathy
por: Noguchi, Masaki, et al.
Publicado: (2023)

Acute Left Circumflex Coronary Artery Occlusion　― Diagnostic Problems of Initial Electrocardiographic Changes ―
por: Komatsu, Junya, et al.
Publicado: (2022)

Unilateral Pulmonary Edema in Patients With Acute Mitral Regurgitation Caused by Chordal Rupture
por: Nishimura, Yu-ki, et al.
Publicado: (2022)

Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension
por: Shimizu, Yuji, et al.
Publicado: (2012)

A Japanese boy with NAA10-related syndrome and hypertrophic cardiomyopathy
por: Shishido, Ayumi, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Soluble Neprilysin　― Cardiac Function and Outcome in Hypertrophic Cardiomyopathy ―
por: Yoshihisa, Akiomi, et al.
Publicado: (2019)

Cardiac imaging with (18)F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathy
por: Takeishi, Yasuchika, et al.
Publicado: (2016)

An Unusual Type of Hypertrophic Cardiomyopathy
por: Seo, Hye-Sun, et al.
Publicado: (2009)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5doh0rg0hs7j49cun902d89gqf